General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

Background: Changing demographics across the UK has led to general practitioners (GPs) managing increasing numbers of older patients with multi-morbidity and resultant polypharmacy. Through government led initiatives within the National Health Service, an increasing number of GP practices employ pha...

Full description

Bibliographic Details
Main Authors: Ahir, H. (Author), Ahmed, M. (Author), Al Azzam, S. (Author), Brady, J. (Author), Fleming, G. (Author), Hogg, A. (Author), Horne, R. (Author), Lawrence, P. (Author), McCrudden, M. (Author), McElnay, J.C (Author), Scott, M.G (Author), Scullin, C. (Author), Syafhan, N.F (Author), Williams, S.D (Author), Wilson, W. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2021
Subjects:
adult
article
clinical pharmacist
Clinical pharmacist
controlled study
cost utility analysis
female
follow up
General practice
general practitioner
health care cost
health status
Healthcare resource utilisation
hospital admission
hospitalization
human
major clinical study
male
Medicines optimisation
multicenter study
outpatient
potentially inappropriate medication
Practice-based pharmacist
quality adjusted life year
randomized controlled trial
risk assessment
teleconsultation
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items